Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ning Jiang, M.d./ph.d.

Clinical trials sponsored by Ning Jiang, M.d./ph.d., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New combo therapy aims to tame tough esophageal cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New combo therapy aims to tame tough esophageal cancer

Disease control Recruiting now

This study tests whether adding the immunotherapy drug camrelizumab to a short course of chemotherapy and radiation can better control advanced esophageal cancer that cannot be removed by surgery. About 98 participants will receive one of two treatment schedules. The goal is to s…

Phase 2 • Sponsor: Ning Jiang, M.D./Ph.D. • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC